BUTAS - Overview: Butalbital, Serum

Monitoring butalbital therapy

CHIKI - Overview: Chikungunya Interpretation

Interpretation of testing that aids in the diagnosis of recent infection with Chikungunya virus in patients with recent travel to endemic areas and a compatible clinical syndrome

MSCG - Overview: Collagenofibrotic Glomerulopathy Confirmation, Mass Spectrometry

Aiding in the diagnosis of collagenofibrotic glomerulopathy

C1Q - Overview: Complement C1q, Serum

Assessment of an undetectable total complement level Diagnosing congenital C1 (first component of complement) deficiency Diagnosing acquired deficiency of C1 inhibitor

CL - Overview: Chloride, Serum

Evaluation of water, electrolyte, and acid-base status

CSU - Overview: Chyluria Screen, Random, Urine

Aiding in the diagnosis of chyluria (galacturia)

8INHT - Overview: Factor VIII Inhibitor Profile, Technical Interpretation

Technical interpretation of inhibitor to factor VIII testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are not specific...

CRSBF - Overview: Crystal Identification, Body Fluid

Identifying the presence and type of crystals in body fluid

BUN - Overview: Blood Urea Nitrogen (BUN), Serum

Screening test for evaluation of kidney function

EOSU1 - Overview: Eosinophils, Random, Urine

Investigation of possible acute interstitial nephritis

MSFNG - Overview: Fibronectin Glomerulopathy Confirmation, Mass Spectrometry

Aiding in the diagnosis of fibronectin glomerulopathy

FLUPV - Overview: Lupus Anticoagulant Evaluation with Reflex

Lupus Anticoagulant Evaluation with Reflex

PBNA - Overview: Lead, Nails

Detecting lead exposure using nail specimens

HGOU - Overview: Mercury Occupational Exposure, Random, Urine

Detecting mercury toxicity due to occupational exposure in random urine specimens

ALUPO - Overview: Lupus Anticoagulant Profile Interpretation

Interpretation of testing performed as part of a profile to confirme or exclude the presence of lupus anticoagulant (LAC), distinguishing LAC from specific coagulation factor inhibitors and nonspecific inhibitors Interpretation of testing...

ATR - Overview: Isoagglutinin Titer, Anti-A, Serum

Evaluation of individuals with possible hypogammaglobulinemia Investigation of suspected roundworm infections

BTR - Overview: Isoagglutinin Titer, Anti-B, Serum

Evaluation of individuals with possible hypogammaglobulinemia

LAGGT - Overview: Granulocyte Antibodies, Serum

Work-up of individuals having febrile, nonhemolytic transfusion reactions Detection of individuals with autoimmune neutropenia This test is not useful for the diagnosis of neutropenia caused by marrow suppression by drugs or tumors.

GLSF - Overview: Glucose, Spinal Fluid

Investigating possible central nervous system infection

FGHTP - Overview: Ghrelin Total (Plasma)

Ghrelin Total (Plasma)

GLUR1 - Overview: Glucose, Random, Urine

Limited usefulness for routine screening or management of diabetes mellitus

MYGLS - Overview: Myoglobin, Serum

Assessing muscle damage from any cause

HGHAR - Overview: Mercury, Hair

Detecting mercury exposure in hair specimens

CMUMP - Overview: Mumps Virus Antibodies, IgG and IgM, Spinal Fluid

Aiding in the diagnosis of central nervous system infection by mumps virus

FNEU - Overview: Neurotransmitter Metabolites (5HIAA, HVA, 3OMD) (CSF)

Neurotransmitter Metabolites (5HIAA, HVA, 3OMD) (CSF)

APRI - Overview: Prolonged Clot Time Profile Interpretation

Interpretation of testing performed as part of a profile to determine the cause of prolongation of prothrombin time or activated partial thromboplastin time Interpretation of testing performed as part of a profile for screening for...

FIBDD - Overview: PROMETHEUS IBD sgi Diagnostic

PROMETHEUS IBD sgi Diagnostic

THSIF - Overview: Thrombospondin Type 1 Domain Containing 7A (THSD7A), Immunofluorescence

Diagnosis of thrombospondin type 1 domain-containing 7A (THSD7A)-associated membranous nephropathy

FSHPU - Overview: Sedative Hypnotic Panel, Urine

Sedative Hypnotic Panel, Urine

FBIOT - Overview: Vitamin B7, H (Biotin)

Vitamin B7, H (Biotin)

FDA1S - Overview: Drugs of Abuse (10 panel) and Alcohol Screen, Serum

Drugs of Abuse (10 panel) and Alcohol Screen, Serum

AMOBS - Overview: Amobarbital, Serum

Monitoring amobarbital therapy

ABOMR - Overview: ABO/Rh, Blood

Determining blood group ABO and Rh only

ALBS1 - Overview: Albumin, Serum

Assessing nutritional status Aiding in the diagnosis of multiple sclerosis when used in conjunction with serum IgG, and cerebrospinal fluid IgG and albumin concentrations

ASHA - Overview: Arsenic, Hair

Detection of nonacute arsenic exposure in hair specimens

NH3V - Overview: Ammonia, Plasma

Assisting in the diagnosis of hepatic coma Investigating and monitoring treatment for inborn errors of metabolism Evaluating patients with advanced liver disease

AST - Overview: Aspartate Aminotransferase (AST) (GOT), Serum

Diagnosing and monitoring liver disease, particularly diseases resulting in a destruction of hepatocytes

ACMA - Overview: Acetaminophen, Serum

Monitoring toxicity in overdose cases

ADMI - Overview: ADAMTS13 Interpretation

Technical interpretation of testing performed to assist in the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura

ALB - Overview: Albumin, Serum

Assessing nutritional status

ALBSF - Overview: Albumin, Spinal Fluid

Assessment of blood-brain barrier permeability

ALS - Overview: Aldolase, Serum

Detection of muscle disease

DIA - Overview: Diazepam and Nordiazepam, Serum

Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity

LEU - Overview: Fecal Leukocytes, Feces

Suggesting the presence of pathogens such as Salmonella, Shigella, and amebiasis

23FBG - Overview: Fibroblast Growth Factor-23 (FGF23), In Situ Hybridization

Assessing fibroblast growth factor-23 (FGF23) expression

CDP - Overview: Chlordiazepoxide and Metabolite, Serum

Monitoring chlordiazepoxide therapy Assessing toxicity

CAFF - Overview: Caffeine, Serum

Monitoring caffeine therapy in neonates Assessing caffeine toxicity in neonates

CZPS - Overview: Clonazepam and 7-Aminoclonazepam, Serum

Assessing patient compliance Monitoring for appropriate therapeutic level Assessing clonazepam toxicity

ETX - Overview: Ethosuximide, Serum

Monitoring ethosuximide therapy Determining compliance Assessing ethosuximide toxicity

REVE0 - Overview: Erythrocytosis Summary Interpretation

Incorporating and summarizing subsequent results into an overall interpretation for the REVE2 / Erythrocytosis Evaluation, Blood